when is retatrutide going to be available Half Life: A Doctor Explains in Simple Terms How Long Does It Take

Step-by-step guide to peptide reconstitution and storage

The injectable drug, initially only used as diabetes medication, is the first drug since Saxenda (2014) approved to treat chronic weight management in the 70% of American adults who are obese or overweight.

They are no longer even pretending to be about improving health

Discover how this once-weekly diabetes medication maintains stable glucose control, why you might notice changing effects, and when to contact your healthcare team for optimal diabetes management.

Conclusion GLP-1RAs show significant promise as a potential disease-modifying therapy for neurodegenerative and inflammatory eye diseases, acting through both systemic metabolic improvements and direct ocular mechanisms, representing a paradigm shift beyond their metabolic indications.

We know that GLP-1 medications can be a powerful tool for weight loss, but they can also come with unwanted side effects